Overview

Efficacy and Safety of Oral Regimens for the Treatment of Chronic HCV Infection

Status:
Completed
Trial end date:
2016-05-09
Target enrollment:
Participant gender:
Summary
This study will evaluate the antiviral efficacy, safety, and tolerability of combination therapy with oral regimens for the treatment of chronic hepatitis C virus (HCV) infection.
Phase:
Phase 2
Details
Lead Sponsor:
Gilead Sciences
Treatments:
Sofosbuvir